Clinical Trials Browser

Phase 2 × Recruiting × Carcinoma, Neuroendocrine × Clear all

NCT06406465 2026-06-05

A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity

Phase 2 Recruiting

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT06893783 2026-04-13

DeLLight

Phase 2 Recruiting

Carcinoma, Neuroendocrine

NCT06333314 2025-12-02

Pan-MSI-ACSE

Phase 2 Recruiting

EndocrineSarcoma

Neoplasm Metastasis, Neoplasms, Sarcoma, Adrenocortical Carcinoma, Carcinoma, Neuroendocrine

NCT04325425 2025-09-30

FOLFIRINEC

Phase 2 Recruiting

Carcinoma, Neuroendocrine

NCT06683846 2025-08-24

Ivonescimab in the Treatment of Multiple Advanced Tumors

Phase 2 Recruiting

CNSDermatologicEndocrineGenitourinarySarcoma

Urachal cancer, Carcinoma, Carcinoma, Basal Cell, Carcinoma, Transitional Cell, Kidney Neoplasms, Paget Disease, Extramammary, Paraganglioma, Penile Neoplasms, Pheochromocytoma, Prostatic Neoplasms, Rhabdomyosarcoma, Sarcoma, Angiomyolipoma, Carcinoma, Neuroendocrine, Perivascular Epithelioid Cell Neoplasms

NCT01876771 2025-08-08

A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours

Phase 2 Recruiting

Carcinoma, Neuroendocrine

NCT04268121 2025-07-23

NEONEC

Phase 2 Recruiting

EndocrineGastrointestinal

Gastrointestinal Neoplasms, Carcinoma, Neuroendocrine